>
Innocoll Holdings logo

INNL - Innocoll Holdings Share Price

$2.35 0.0  0.0%

Last Trade - 21/07/17

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £2.91m
Position in Universe th / 6850
Bullish
Bearish
Unlock INNL Revenue
Momentum
Relative Strength (%)
1m -1.06%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2011 2012 2013 2014 2015 2016 2017E 2018E CAGR / Avg
0.000 5.54 4.71 5.97 2.87 4.37 3.75 4.71 -5.8%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 31 March 2017, InnocollHoldings PLC revenues decreased 23% to $1.2M. Net lossdecreased 45% to $12.7M. Revenues reflect a decrease indemand for the Company's products and services due tounfavorable market conditions. Basic Earnings per Shareexcluding Extraordinary Items increased from -$0.97 to-$0.43.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

INNL Revenue Unlock INNL Revenue

Net Income

INNL Net Income Unlock INNL Revenue

Normalised EPS

INNL Normalised EPS Unlock INNL Revenue

PE Ratio Range

INNL PE Ratio Range Unlock INNL Revenue

Dividend Yield Range

INNL Dividend Yield Range Unlock INNL Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
INNL EPS Forecasts Unlock INNL Revenue
Profile Summary

Innocoll Holdings Public Limited Company is a commercial-stage specialty pharmaceutical and medical device company with late-stage development programs. The Company operates through the segment of manufacture and sale of collagen-based pharmaceutical products. It utilizes collagen-based technology platform to develop its biodegradable and bioresorbable products and product candidates, which can be broken down by the body without the need for surgical removal or applied topically. Using its processes at its manufacturing facility, it derives and purifies bovine and equine collagen and then utilizes its technology platform to incorporate the purified collagen into its topical and implantable products. Its lead product candidates are XaraColl for the treatment of post-operative pain and Cogenzia for the treatment of diabetic foot infections. Its marketed products include CollaGUARD, Collatamp, Septocoll and RegenePro. It has initiated its Phase III efficacy trials for Cogenzia.

Directors
Last Annual December 31st, 2016
Last Interim March 31st, 2017
Incorporated May 28, 2014
Public Since July 25, 2014
No. of Shareholders: n/a
No. of Employees: 105
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange NASDAQ Global Market
Shares in Issue 30,095,931
Free Float (0.0%)
Eligible for
ISAs
SIPPs
INNL Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for INNL
Upcoming Events for INNL
Frequently Asked Questions for Innocoll Holdings
What is the Innocoll Holdings share price?

As of 21/07/17, shares in Innocoll Holdings are trading at $2.35, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Innocoll Holdings share price performed this year?

Shares in Innocoll Holdings are currently trading at $2.35 and the price has moved by -57.35% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Innocoll Holdings price has moved by -70.6% over the past year.

What are the analyst and broker recommendations for Innocoll Holdings?

Of the analysts with advisory recommendations for Innocoll Holdings, there are there are currently 0 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Innocoll Holdings is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Innocoll Holdings next release its financial results?

Innocoll Holdings is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2018-03-31
What is the Innocoll Holdings dividend yield?

Innocoll Holdings does not currently pay a dividend.

Does Innocoll Holdings pay a dividend?

Innocoll Holdings does not currently pay a dividend.

When does Innocoll Holdings next pay dividends?

Innocoll Holdings does not currently pay a dividend.

How do I buy Innocoll Holdings shares?

To buy shares in Innocoll Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Innocoll Holdings?

Shares in Innocoll Holdings are currently trading at $2.35, giving the company a market capitalisation of £n/a.

Where are Innocoll Holdings shares listed? Where are Innocoll Holdings shares listed?

Here are the trading details for Innocoll Holdings:

Country of listing: United States
Exchange: NMQ
Ticker Symbol: INNL
What kind of share is Innocoll Holdings?

We were not able to load our ranking data for Innocoll Holdings

Is there a Innocoll Holdings share price forecast 2021?

We were not able to load any forecast data for Innocoll Holdings.

How can I tell whether the Innocoll Holdings share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Innocoll Holdings. Over the past six months, the relative strength of its shares against the market has been 0.176k%. At the current price of $2.35, shares in Innocoll Holdings are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Innocoll Holdings PE Ratio?

We were not able to find PE ratio data for Innocoll Holdings.

Who are the key directors of Innocoll Holdings?

We were unable to find the directors for Innocoll Holdings.

Who are the major shareholders of Innocoll Holdings?

Here are the top five shareholders of Innocoll Holdings based on the size of their shareholding:

Similar to INNL
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.